Contact Congress about H.R. 5269: RESULTS Act

Medicare would change how it pays for many lab tests. It would use a large national claims database to help set prices and would limit how fast some payments can fall.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

RESULTS Act is a House bill in committee. The latest recorded action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Latest action on H.R. 5269: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Who this affects: This bill mainly affects Medicare patients, clinical labs, and the Department of Health and Human Services. Patients could feel the change if payment rates affect which lab tests remain easy to get. Labs would face updated reporting rules and new payment calculations. The federal government would need to contract with a qualified claims data group and explain its rate decisions more clearly.

Why this matters: Lab test payment rates can affect whether patients can get needed tests without delay. This bill tries to make Medicare rates reflect broader market prices while avoiding sharp payment drops. It could also reduce reporting work for some labs and make Medicare’s rate math easier to check. The size and direction of payment changes are not set in the bill.

Key provisions in H.R. 5269

• Starting with 2027 data collection, Medicare would use a national nonprofit claims data group for many common lab tests. This applies to widely available non-advanced diagnostic lab tests and private payor payment data.
• The claims database would have to meet strict standards. It must include at least 50 billion claims, more than 50 private payors, nationwide data, quality checks, and full privacy and security compliance.
• For data periods starting January 1, 2027, Medicare would count only final payment rates actually paid by private payors. It would also count test volume at those rates, but not denied, appealed, mistaken, or recouped payments.
• For reporting periods from 2028 onward, the bill updates which labs must report data. It uses the federal rule at 42 C.F.R. 414.502 as it stood on May 1, 2025, with one listed exception.
• A non-advanced test would count as widely available if more than 100 different Medicare providers or suppliers billed for it. The count happens during the first six months of the year before data collection.

How Modern Action helps you take action on H.R. 5269

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about H.R. 5269

What is H.R. 5269?

Medicare would change how it pays for many lab tests. It would use a large national claims database to help set prices and would limit how fast some payments can fall.

How do I support or oppose H.R. 5269?

Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.

Who should I contact about H.R. 5269?

Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.

Can Modern Action explain H.R. 5269 before I act?

Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.